Urology Surgical Instruments Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Endoscopes, Envision Systems, Peripheral Systems, Accessories & Consumables, Others), By Application (Chronic Kidney Disease, Benign Prostatic Hyperplasia (BPH), Urinary Stones, Urinary Incontinence (UI) and Pelvic Organ Prolapse (POP), Oncology, Others), By Region and Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 11.98 Billion
CAGR (2026-2031)	7.92%
Fastest Growing Segment	Endoscopes
Largest Market	North America
Market Size (2031)	USD 18.93 Billion

Market Overview

The Global Urology Surgical Instruments Market will grow from USD 11.98 Billion in 2025 to USD 18.93 Billion by 2031 at a 7.92% CAGR. The Global Urology Surgical Instruments Market encompasses a specialized category of medical devices, including endoscopes, laser systems, lithotripters, and robotic platforms, designed for the diagnosis and treatment of disorders affecting the urinary tract and male reproductive organs. The primary drivers propelling this market are the rapidly aging global population and the rising prevalence of urological malignancies and chronic kidney conditions, which necessitate frequent surgical intervention. According to the American Cancer Society, in 2025, there are an estimated 313,780 new cases of prostate cancer projected in the United States, underscoring the critical demand for precise surgical tools to manage this high disease burden.

Despite these strong growth indicators, the market faces a significant impediment regarding the shortage of skilled specialists required to operate these complex instruments. This workforce gap restricts the volume of procedures that can be performed, particularly in underserved regions, thereby limiting equipment adoption. According to the American Urological Association, in 2025, reported data indicated that 62% of counties in the United States do not have a practicing urologist, highlighting a severe distribution challenge that constrains procedural capacity and market expansion.

Key Market Drivers

Technological advancements in robotic-assisted and laser surgery constitute a primary catalyst for market growth by enhancing surgical precision and reducing patient recovery times. These innovations have shifted clinical preference toward minimally invasive modalities, allowing surgeons to perform complex procedures such as prostatectomies and nephrectomies with greater efficacy and reduced intraoperative complications. The integration of high-definition imaging and articulation in robotic platforms drives significant equipment adoption in hospitals aiming to offer superior care standards. This operational shift is quantitatively evident in procedure volumes. According to Intuitive Surgical, January 2024, in the 'Preliminary Fourth Quarter and Full Year 2023 Results' press release, worldwide da Vinci procedures grew approximately 22% in 2023 compared with 2022, underscoring the rapid expansion of robotic utilization in urological interventions.

The rising incidence of urological disorders and chronic kidney diseases (CKD) further amplifies the demand for specialized diagnostic and surgical tools. As the global burden of conditions like kidney stones, urinary incontinence, and renal failure expands, there is a parallel need for endoscopes, lithotripters, and dialysis-related surgical devices to manage this growing patient population. According to Kidney Care UK, May 2024, in the 'Facts about kidneys' article, it is estimated that around 7.2 million people in the United Kingdom have chronic kidney disease stages 1-5, representing a significant volume of patients potentially requiring long-term urological management. This elevated disease burden directly translates into financial expansion for major device manufacturers catering to this specific demand. According to Boston Scientific, in 2024, the company reported that its Urology business generated net sales of $1.964 billion in 2023, representing a 10.8% increase driven by strong performance in stone management portfolios.

Download Free Sample Report

Key Market Challenges

The scarcity of qualified specialists capable of operating complex urological devices presents a substantial barrier to market progress. Surgical instruments require highly trained professionals for safe operation, yet the available workforce is struggling to keep pace with procedural demand. When healthcare facilities lack the necessary personnel to perform specialized interventions, they are less likely to invest in additional equipment, directly reducing procurement volumes and stalling inventory turnover. This workforce constraint effectively places a cap on the total addressable market regardless of rising patient needs.

This contraction in available labor is further exacerbated by demographic shifts within the medical specialty itself. According to the American Urological Association, in 2024, approximately 30 percent of practicing urologists in the United States were aged 65 years or older, signaling an impending wave of retirements that threatens to widen the existing supply gap. Consequently, the inability to fully staff urology departments limits the frequency of surgical procedures, thereby restricting the adoption rate of instrumentation and dampening revenue potential for device manufacturers.

Key Market Trends

The Rapid Transition to Single-Use Disposable Ureteroscopes and Cystoscopes is fundamentally altering procurement strategies as healthcare providers prioritize infection control and operational efficiency. Unlike traditional reusable devices that require costly and time-consuming reprocessing, single-use instruments eliminate cross-contamination risks and ensure consistent performance without maintenance downtime. This shift is particularly evident in high-volume settings where sterilization delays can bottleneck procedural throughput, prompting hospitals to switch to sterile alternatives. The accelerating adoption of these devices is financially visible in the performance of market innovators. According to Ambu A/S, January 2025, in the 'Interim Report for Q1 2024/25', the company's Urology, ENT, and GI business group posted 23.9% organic revenue growth, driven largely by the sustained demand for its disposable ureteroscopy solutions.

The Development of Smart Surgical Instruments with Real-Time Connectivity represents a significant evolution beyond standard robotic assistance. Manufacturers are now integrating massive computing power and sensing technologies into next-generation platforms to provide surgeons with haptic feedback and actionable insights, surpassing the capabilities of purely mechanical tele-manipulators. These intelligent systems leverage data to optimize clinical workflows and offer advanced simulation training, thereby enhancing surgeon proficiency and decision-making capabilities. Market uptake of these sophisticated platforms has been immediate as institutions seek to upgrade their technological infrastructure. According to Intuitive Surgical, January 2025, in a presentation at the J.P. Morgan Healthcare Conference, the company reported that 362 units of its latest da Vinci 5 system had been placed with customers since its commercial launch.

Segmental Insights

Based on authoritative market analysis, Endoscopes represent the fastest-growing segment in the Global Urology Surgical Instruments Market. This rapid expansion is primarily driven by the widespread shift toward minimally invasive surgeries, which offer reduced patient recovery times and lower infection risks compared to traditional open procedures. The growth is further propelled by the rising prevalence of urological disorders, such as kidney stones and bladder cancer, which necessitate frequent endoscopic diagnosis and treatment. Additionally, the increasing adoption of single-use disposable endoscopes to mitigate cross-contamination risks and comply with stringent safety standards is significantly accelerating the demand for these devices globally.

Regional Insights

North America maintains a dominant position in the Global Urology Surgical Instruments Market, driven by a well-established healthcare infrastructure and high healthcare expenditure. The region faces a rising prevalence of urological disorders, particularly among the aging population, which necessitates frequent surgical interventions. Additionally, the strong presence of key industry manufacturers ensures steady product accessibility across medical facilities. Favorable reimbursement policies established by the Centers for Medicare & Medicaid Services (CMS) further encourage the adoption of essential surgical tools, solidifying the region's leadership in this sector.

Recent Developments

• In September 2024, Olympus Corporation announced the launch of a new 4K camera head, the CH-S700-08-LB, specifically designed for endoscopic urology and gynecology procedures. This device was compatible with the VISERA ELITE III video system center and provided four times the pixel count of conventional high-definition models. The camera head featured Blue Light observation capabilities to support the diagnosis and treatment of bladder cancer. By delivering enhanced image clarity and versatile imaging functions, this product launch strengthened the company's portfolio within the Global Urology Surgical Instruments Market, aiming to improve early diagnosis and minimally invasive treatment standards.
• In July 2024, Ambu announced that it had received 510(k) clearance from the U.S. Food and Drug Administration for its single-use ureteroscopy solution, the aScope 5 Uretero. This clearance accompanied the approval of the aBox 2 full-HD endoscopy system, marking a significant expansion of the company's presence in the United States. The aScope 5 Uretero was the first ureteroscope constructed with bioplastics, addressing sustainability concerns while providing high-quality imaging and maneuverability for urologists. This development underscored a progressive shift toward single-use devices in the Global Urology Surgical Instruments Market, aiming to enhance workflow efficiency and patient safety.
• In April 2024, Teleflex Incorporated announced the full market release of the UroLift 2 System with Advanced Tissue Control for the treatment of benign prostatic hyperplasia. This unified platform was designed to treat patients with various prostate types and sizes, including those up to 100g. The system featured tissue control wings and laser-etched needle markers to provide urologists with improved targeting accuracy and confidence during implant delivery. This launch represented a significant advancement in the Global Urology Surgical Instruments Market, offering a minimally invasive solution that preserved sexual function and streamlined procedural efficiency for physicians.
• In March 2024, Intuitive Surgical announced that it received 510(k) clearance from the U.S. Food and Drug Administration for its fifth-generation robotic system, the da Vinci 5. This next-generation multiport robotic system was designed to improve accuracy and precision for surgeons and care teams during minimally invasive procedures, including urological surgeries. The system introduced first-of-its-kind force-sensing technology, which enabled surgeons to feel subtle forces exerted on tissue. This advancement aimed to reduce tissue trauma and enhance patient outcomes in the Global Urology Surgical Instruments Market by providing superior visualization and ergonomic controls.

Key Market Players

• Medtronic plc
• Boston scientific corporation
• Karl Storz GmbH & Co. KG
• Cook Medical Inc
• Richard Wolf GmbH
• Teleflex Incorporated
• Coloplast Corp.
• CONMED Corporation
• C. R. Bard Inc.
• Olympus Corporation

By Product	By Application	By Region
Endoscopes Envision Systems Peripheral Systems Accessories & Consumables Others	Chronic Kidney Disease Benign Prostatic Hyperplasia (BPH) Urinary Stones Urinary Incontinence (UI) and Pelvic Organ Prolapse (POP) Oncology Others	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Urology Surgical Instruments Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Urology Surgical Instruments Market, By Product:

• Endoscopes
• Envision Systems
• Peripheral Systems
• Accessories & Consumables
• Others

• Urology Surgical Instruments Market, By Application:

• Chronic Kidney Disease
• Benign Prostatic Hyperplasia (BPH)
• Urinary Stones
• Urinary Incontinence (UI) and Pelvic Organ Prolapse (POP)
• Oncology
• Others

• Urology Surgical Instruments Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE